InvestorsHub Logo
Followers 8
Posts 837
Boards Moderated 0
Alias Born 03/06/2019

Re: None

Tuesday, 03/16/2021 12:37:42 PM

Tuesday, March 16, 2021 12:37:42 PM

Post# of 43360
"It would be significant if the Phase III results match the interim lenzilumab results, said Badley, adding it would see wide uptake if approved."

https://www.clinicaltrialsarena.com/comment/humanigens-and-kiniksas-anti-gm-csf-antibodies-likely-to-garner-a-place-for-nonventilated-covid-19-patients/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.